The Claim
Daily administration of liraglutide at 1.8 mg for 14 weeks in individuals with obesity and prediabetes causes a rapid, weight loss–independent improvement in insulin sensitivity, as measured by HOMA-IR, HOMA2, and Matsuda index, with significant improvements observed within 2 weeks before any meaningful weight reduction occurs.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In people with obesity and prediabetes, taking liraglutide 1.8 mg daily for 14 weeks improves insulin sensitivity within two weeks, independent of weight loss.
See the scientific wording
In individuals with obesity and prediabetes, daily administration of liraglutide at 1.8 mg for 14 weeks causes a rapid, weight loss–independent improvement in insulin sensitivity, as measured by HOMA-IR, HOMA2, and Matsuda index, with significant improvements observed within 2 weeks before any meaningful weight reduction occurs.
Liraglutide binds to GLP-1 receptors on pancreatic cells, which stops the liver from releasing too much sugar and reduces the amount of insulin the body needs to control blood sugar. This happens quickly, before any weight loss, because the drug directly changes how the pancreas and liver work together.
What the research says
1 studyThis study shows that the drug liraglutide helps the body use insulin better within just two weeks—even before people lose any weight—because it directly activates a specific receptor in the body. Other ways to boost the same natural hormone didn’t have the same effect.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.